ArcherDX Competitors, Revenue, Alternatives and Pricing

Claim your profile


Boulder, CO USA
Total Funding:$150M
Lead Investor(s):Boulder Ventures, PBM Capital Group, LLC

Estimated Revenue & Financials

  • ArcherDX's estimated annual revenue is currently $27.4M per year.(?)
  • ArcherDX received $35.0M in venture funding in March 2018.
  • ArcherDX's estimated revenue per employee is $155,000
  • ArcherDX's total funding is $150M.

Employee Data

  • ArcherDX has 177 Employees.(?)
  • ArcherDX grew their employee count by -39% last year.
  • ArcherDX currently has 16 job openings.

ArcherDX, Inc., creates catalog and custom next-generation sequencing (NGS) assays that are purpose-built to identify mutations and gene fusions from clinical sample types. By combining novel enrichment chemistry, automated informatics and a user-friendly workflow, Archer products remove the bottlenecks associated with using next-gen sequencing in a translational setting.

keywords:Biotechnology,Healthcare,Medical Diagnostics,Pharmaceuticals